Do your pre-trained AI models require proprietary information about a company’s investigational compound?

Using the compound structure (i.e. SMILES) will result in the most accurate efficacy predictions. However, depending on the stage of development we can also work with a substitute for the molecular structure, such as the drug targets/biomarkers. We can also develop customized AI models for a particular drug; these require only available response data.